UK small-cap RNS · 26 Jan 2026
The key announcements of UK small & mid caps under £2bn on 26 Jan 2026 – situations they move are marked, with the share price since.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus director dealings and holdings that are part of a situation. Not investment advice.
| Date | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 26 Jan | Coro Energy CORO | £3.1m | Overhang | Holding(s) in Company | |
| 26 Jan | Mode Global Holdings MODE | £0.5m | Legal & regulatory | Unaudited interim results
The Company is pleased to announce its unaudited interim results for the six months ended 30 |
|
| 26 Jan | Quantum Helium Limited QHE | £7.7m | Project milestones | BIA Approval of Irrevocable Letter of Credit
Quantum Helium Limited (AIM: QHE) is pleased to announce that the Irrevocable Letter of Credit ("ILOC") required for bonding has now been formally approved by the U.S. |
|
| 26 Jan | Nanoco Group NANO | £4.8m | Turnaround plan with targets | Conclusion of CDX process & Directorate changes
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, announces that, following an extensive exercise in relation to a potential … |
|
| 26 Jan | Georgina Energy plc GEX | £27m | Project milestones | Hussar EP513 Drilling/Funding
Georgina Energy Plc, GEX.L advises Harlequin Energy Ltd ('Harlequin') has formally confirmed its intention to proceed with funding for the Hussar EP513 prospect for the anticipated recovery of Helium, Hydrogen and Natural Gas. |
|
| 26 Jan | Kavango Resources KAV | £28m | Project milestones | Successful Diamond Drilling at Bill’s Luck
Successful diamond resource drilling programme at Bill's Luck Gold Mine |
|
| 26 Jan | Costain Group COST | £651m | Capital return | New Pension Scheme Agreement & FY25 Trading Update
Update on New Pension Scheme Agreement, Enhanced Shareholder Returns and FY 25 Trading |
|
| 26 Jan | Venture Life Group VLG | £80m | Capital return | Trading Update
Venture Life (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces a trading update for the twelve-month period ended 31 December 2025 (the "Period"). |
|
| 26 Jan | Scancell Holdings SCLP | £124m | Project milestones | FDA clearance of IND application for iSCIB1+
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma |